Global Transcatheter Aortic Valve Replacement (TAVR) Market: Trends & Opportunities (2013-18) – New Report by Daedal Research

Delhi, India, August 28, 2013 --(PR.com)-- The report assesses the current and forecasted sizing of the market on the global level and also provides insight into the number of TAVR procedures performed worldwide. Further, the report analyzes the two major markets of the TAVR procedures - Europe and the United States. The report also analyzes the market share of the major players operating in the business and the various factors driving the TAVR procedure and the recent developments in the market. The report concludes with the future outlook of the TAVR market and profiles the leading players like Edward Lifesciences, Medtronic and St. Jude Medical and their business strategies and upcoming technologies in the Transcatheter Aortic Valve Replacement market.
Company Coverage

Edward Lifesciences
Medtronic
St. Jude Medical
Boston Scientific

Executive Summary
Recent advancements in biomedical engineering and technology have paved the way for a procedure known as Transcatheter Aortic Valve Replacement (TAVR) or Transcatheter Aortic Valve Implantation (TAVI). TAVR is a less invasive method of replacing the heart valve and has emerged as the most feasible alternative to conventional surgical aortic valve replacement. TAVR is a very promising market with lot of unmet opportunities and demands to cater to. Currently, the market is only prevalent in parts of Europe and United States and is expected to expand in the Asia Pacific and Middle East region very soon.

TAVR is a relatively very new technology in the medical business. First commercially launched in Europe in 2007 and later in the United States, the market holds immense business opportunities. With the emergence of this minimally invasive transcatheter heart valve repair technique, a significant change is expected in the valve replacement technology as the invention reduces the risks and costs associated with other heart surgeries. Further, the procedure adheres to the Food and Drug Administration (FDA) norms and policies and this will play a crucial role in shaping the structure of the market in the future.

Table of Contents:

1. Executive Summary

2. Transcatheter Aortic Valve Replacement (TAVR) Market: An Overview

3. Global TAVR Market: An Analysis

3.1. Market Sizing and Growth: Actual and Forecast
3.2. Global TAVI Procedures
3.3. Statistical Analysis of Inoperable Severe AS Patient and TAVR Penetration: Worldwide
3.4. Statistical Analysis of Surgical AVR Patients and TAVR Penetration: Worldwide
3.5. Global TAVR Market Share Analysis

3.5.1. Market Share: By Major Players
3.5.2. Market Share: By Region

4. TAVR Market: Regional Analysis

4.1. United States TAVR Market: An Analysis

4.1.1. Market Sizing and Growth: Actual and Forecast
4.1.2. Market Share: By Major Players

4.2. Europe TAVR Market: An Analysis

4.2.1. Market Sizing and Growth: Actual and Forecast
4.2.2. Market Share: By Major Players
4.2.3. TAVR Implants in Europe: By Country
4.2.4. TAVR Centers in Europe: By Country

4.3. Rest of the world

4.3.1. Market Sizing and Growth: Actual and Forecast

5. Growth Drivers of TAVR Market

6. TAVR Market: Recent Developments

7. Future Outlook: New Clinical and Technological Indication in TAVR Market

8. Competitive Landscape: Global TAVR Market

9. Company Analysis: Global TAVR Market

9.1. Edwards Lifesciences
9.1.1. Business Description
9.1.2. Business Strategies
9.1.3. Revenue Analysis
9.1.4. Market Share Analysis

9.2. Medtronic
9.2.1. Business Description
9.2.2. Business strategies
9.2.3. Revenue Analysis
9.2.4. Market Share Analysis

9.3. St Jude Medical
9.3.1. Business Description
9.3.2. Business Strategies

9.4. Boston Scientific
9.4.1. Business Description
9.4.2. Business Strategies

For further details, kindly visit :
http://www.daedal-research.com/global-transcatheter-aortic-valve-replacement-tavr-market-trends-opportunities-2013-18

Rajeev Kumar
(Business Development Manager)
Address: 36 SFS Flats
Paschim Vihar
New Delhi-110063
Mobile: +91-8743975789
Tel: +91-120-4553017